Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Garmo

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
European Journal of Clinical Pharmacology|May 8, 2012
Anti-androgen prescribing patterns, patient treatment adherence and influencing factors; results from the nationwide PCBaSe SwedenB Grundmark, H Garmo, B Zethelius, et al.
Scandinavian Journal of Surgery : SJS : Official Organ for the Finnish Surgical Society and the Scandinavian Surgical Society|October 8, 2019
Primary small intestinal neuroendocrine tumors are highly prevalent and often multiple before metastatic disease developsJ Eriksson, O Norlén, M Ögren, et al.
Cancer Epidemiology|June 14, 2014
Incidence of bone metastases and survival after a diagnosis of bone metastases in breast cancer patientsM Harries, A Taylor, L Holmberg, et al.
British Journal of Cancer|December 18, 2008
Incidence and mortality of incidental prostate cancer: a Swedish register-based studyO Andrèn, H Garmo, L Mucci, et al.
The British Journal of Surgery|August 1, 2009
Follow-up may not be beneficial after treatment of grade 1 breast cancerM Kontos, D Allen, D T Trafalis, et al.
British Journal of Cancer|June 28, 2012
Patterns of metastasis in women with metachronous contralateral breast cancerV Vichapat, H Garmo, L Holmberg, et al.
Breast Cancer Research and Treatment|July 22, 2018
Determinants of non-adherence to adjuvant endocrine treatment in women with breast cancer: the role of comorbidityW Wulaningsih, H Garmo, J Ahlgren, et al.
The Pharmacogenomics Journal|February 24, 2010
Prediction of irinotecan and 5-fluorouracil toxicity and response in patients with advanced colorectal cancerB Glimelius, H Garmo, A Berglund, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 7, 2022
Risk of coronary stenosis after adjuvant radiotherapy for breast cancerA-K Wennstig, H Garmo, L Wadsten, et al.
Breast Cancer Research and Treatment|May 7, 2018
Risk of ischemic heart disease after radiotherapy for ductal carcinoma in situC Wadsten, A-K Wennstig, H Garmo, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
European Journal of Clinical Pharmacology|May 8, 2012
Anti-androgen prescribing patterns, patient treatment adherence and influencing factors; results from the nationwide PCBaSe SwedenB Grundmark, H Garmo, B Zethelius, et al.
Scandinavian Journal of Surgery : SJS : Official Organ for the Finnish Surgical Society and the Scandinavian Surgical Society|October 8, 2019
Primary small intestinal neuroendocrine tumors are highly prevalent and often multiple before metastatic disease developsJ Eriksson, O Norlén, M Ögren, et al.
Cancer Epidemiology|June 14, 2014
Incidence of bone metastases and survival after a diagnosis of bone metastases in breast cancer patientsM Harries, A Taylor, L Holmberg, et al.
British Journal of Cancer|December 18, 2008
Incidence and mortality of incidental prostate cancer: a Swedish register-based studyO Andrèn, H Garmo, L Mucci, et al.
The British Journal of Surgery|August 1, 2009
Follow-up may not be beneficial after treatment of grade 1 breast cancerM Kontos, D Allen, D T Trafalis, et al.
British Journal of Cancer|June 28, 2012
Patterns of metastasis in women with metachronous contralateral breast cancerV Vichapat, H Garmo, L Holmberg, et al.
Breast Cancer Research and Treatment|July 22, 2018
Determinants of non-adherence to adjuvant endocrine treatment in women with breast cancer: the role of comorbidityW Wulaningsih, H Garmo, J Ahlgren, et al.
The Pharmacogenomics Journal|February 24, 2010
Prediction of irinotecan and 5-fluorouracil toxicity and response in patients with advanced colorectal cancerB Glimelius, H Garmo, A Berglund, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 7, 2022
Risk of coronary stenosis after adjuvant radiotherapy for breast cancerA-K Wennstig, H Garmo, L Wadsten, et al.
Breast Cancer Research and Treatment|May 7, 2018
Risk of ischemic heart disease after radiotherapy for ductal carcinoma in situC Wadsten, A-K Wennstig, H Garmo, et al.
Pageof 3